Randomized Controlled Trial
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. May 27, 2016; 8(5): 382-388
Published online May 27, 2016. doi: 10.4240/wjgs.v8.i5.382
Enhanced recovery program is safe and improves postoperative insulin resistance in gastrectomy
Nobuaki Fujikuni, Kazuaki Tanabe, Noriaki Tokumoto, Takahisa Suzuki, Minoru Hattori, Toshihiro Misumi, Hideki Ohdan
Nobuaki Fujikuni, Kazuaki Tanabe, Minoru Hattori, Toshihiro Misumi, Hideki Ohdan, Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima 734-8551, Japan
Noriaki Tokumoto, Department of Surgery, Hiroshima City Hospital, Hiroshima 730-8518, Japan
Takahisa Suzuki, Department of Surgery, Hiroshima Prefectural Hospital, Hiroshima 734-8530, Japan
Author contributions: Tanabe K, Tokumoto N, Suzuki T and Ohdan H concept and designed this study; Fujikuni N, Tanabe K, Tokumoto N, Suzuki T and Misumi T were the clinical investigators with more patients recruited and treated; Fujikuni N and Hattori M analyzed the data; Fujikuni N and Tanabe K drafted the manuscript and made the final approved the version to be published.
Institutional review board statement: The study was reviewed and approved by the institutional review board of the study institution (Hiroshima University, Japan).
Clinical trial registration statement: This study is registered at UMIN Clinical Trials Registry. The registration identification number is UMIN000020538.
Informed consent statement: All study participants provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Data sharing statement: Dataset is available from the corresponding author at ktanabe2@hiroshima-u.ac.jp.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Kazuaki Tanabe, MD, PhD, Department of Gastroenterological and Transplant Surgery, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. ktanabe2@hiroshima-u.ac.jp
Telephone: +81-82-2575222 Fax: +81-82-2575224
Received: December 26, 2015
Peer-review started: December 27, 2015
First decision: January 30, 2016
Revised: February 12, 2016
Accepted: March 14, 2016
Article in press: March 16, 2016
Published online: May 27, 2016
Processing time: 142 Days and 16.7 Hours
Core Tip

Core tip: We conducted a prospective study in gastrectomy patients to evaluate the efficacy of enhanced recovery after surgery (ERAS) programs. ERAS was safe and improved insulin resistance in these patients.